Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy
Purpose High activity of enzyme TOP2a in tumor cells is known to be associated with sensitivity to anthracycline chemotherapy, but 20% of such patients do not show clinical response. Tumor microenvironment, including tumor-associated macrophages (TAM), is an essential factor defining the efficiency...
Published in: | Cancer chemotherapy and pharmacology Vol. 82, № 1. P. 99-109 |
---|---|
Other Authors: | Tsyganov, Matvey M., Larionova, Irina V, Ibragimova, Marina K., Deryusheva, Irina V., Kazantseva, Polina V., Slonimskaya, Elena M., Frolova, Irina G., Choinzonov, Evgeny L., Cherdyntseva, Nadezhda V., Litvyakov, Nicolay V., Kzhyshkowska, Julia G. |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000634057 Перейти в каталог НБ ТГУ |
Similar Items
- Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy
- Effect of neoadjuvant chemotherapy on correlation of tumor-associated macrophages with angiogenesis and lymphangiogenesis in human breast cancer
- The effect of neoadjuvant chemotherapy on the correlation of tumor-associated macrophages with CD31 and LYVE-1
- Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy
- CNA landscape of breast tumor, connection with the efficiency of neoadjuvant chemotherapy